How Menopause Treatments like HRT can help our Workforce Prevent Cardiovascular Disease

Posted on October 16, 2023 by Sally-Anne Turner

The menopause is so often seen as a woman's issue, a private matter, and an insulting accusation, with extreme stigmatisation in the workforce. However, the statistics do not lie; menopausal women make up the fastest-growing demographic in the UK workforce. This demographic shift represents not just a social change but a significant economic and public health consideration that forward-thinking employers can no longer afford to ignore.

Women between the ages of 45 and 54 are most likely to be of menopause age and make up 11% of the UK workforce, as well as 23% of the women in the workforce. These working women will be experienced and knowledgeable and should be reaching the most successful part of their careers. They represent decades of institutional knowledge, leadership experience, and professional expertise that organisations have invested considerable resources in developing. Yet without the appropriate resources, support, and education, they could be falling through the cracks thanks to debilitating symptoms and health repercussions of the menopause.

The economic implications of this situation are staggering. When experienced professionals leave the workforce prematurely due to unmanaged menopausal symptoms or related health complications, businesses lose not only their day-to-day contributions but also their mentorship capabilities, client relationships, and the cultural knowledge they've accumulated over years of service. The cost of replacing senior staff members extends far beyond recruitment expenses, encompassing training, onboarding, and the productivity gap that inevitably occurs during transitions.

An inquiry led by the House of Commons' Women and Equalities Committee found that the most commonly reported symptoms of menopause were difficulty sleeping, problems with memory and concentration, and hot flashes. 72% and 69% of the women surveyed also suffered from night sweats and anxiety/depression, respectively. These symptoms don't simply disappear when women enter the workplace; they follow them into meetings, presentations, client interactions, and strategic decision-making moments.

"Most respondents reported that these symptoms affected them at work, reporting a loss of ability to concentrate, increased stress and a loss of confidence. 31% of respondents took time off work due to symptoms." The impact of these symptoms extends beyond individual suffering to affect team dynamics, project timelines, and organisational performance. When a key team member struggles with concentration or needs to take unexpected leave, the ripple effects touch everyone in the organisation.

The Hidden Health Crisis: Menopause and Cardiovascular Disease

However, it is not just menopausal symptoms that have an impact on the workforce. It is also the increase in risk of heart disease, strokes, and high blood pressure that comes with the change. The risk of cardiovascular disease significantly increases once a woman goes through menopause, according to the British Heart Foundation. This connection between menopause and heart health represents one of the most significant yet under-discussed public health challenges facing working women today.

Before menopause, women generally have a lower risk of cardiovascular disease compared to men of the same age. This protective effect is largely attributed to oestrogen, which helps maintain healthy blood vessels, regulates cholesterol levels, and supports overall cardiovascular function. However, as oestrogen levels decline during perimenopause and menopause, this protective advantage diminishes rapidly. Within just a few years after menopause, women's cardiovascular risk begins to match and can even exceed that of their male counterparts.

The physiological changes that occur during menopause create a perfect storm for cardiovascular problems. Beyond the loss of oestrogen's protective effects, menopausal women often experience changes in body composition, with increased visceral fat accumulation around the abdomen. This type of fat is particularly dangerous, as it's metabolically active and contributes to insulin resistance, inflammation, and dyslipidaemia—all major risk factors for heart disease. Sleep disruption, another common menopausal symptom, further compounds cardiovascular risk by affecting blood pressure regulation and metabolic health.

Contact Bodyline today to find out more about our hormone replacement therapy treatments

Death before retirement age is very commonly due to cardiovascular disease, accounting for 36% of premature deaths in men and 27% of premature deaths in women. Menopause and cardiovascular disease are inextricably linked, and both separately and together pose a dangerous risk to the health and longevity of the UK workforce and its economic productivity. When we consider that women are increasingly delaying retirement and remaining in the workforce longer than previous generations, the importance of managing menopausal health and cardiovascular risk becomes even more critical.

The workplace impact of cardiovascular disease among menopausal women manifests in multiple ways. There's the obvious concern of acute events—heart attacks or strokes occurring during working years—which can result in permanent disability, long-term absence, or tragic loss of life. However, there's also the less visible but equally significant impact of subclinical cardiovascular disease, where women may experience fatigue, reduced stamina, chest discomfort, or shortness of breath that limits their ability to perform at their best without necessarily triggering a medical crisis.

For employers, the financial implications are substantial. Healthcare costs associated with cardiovascular disease are among the highest of any chronic condition. The indirect costs—including reduced productivity, increased absenteeism, presenteeism (being at work but not fully functioning), and early retirement—add significantly to the burden. Progressive organisations are beginning to recognise that investing in preventative health measures, particularly for their menopausal workforce, represents not just a moral imperative but a sound business strategy.

The Evidence for HRT in Cardiovascular Protection

Yet, countless studies are showing that the short-term use of hormonal replacement therapy (HRT) on menopausal women not only decreases symptom severity, but also the risk of heart and cardiovascular disease: "HRT significantly reduces all-cause mortality and cardiovascular disease (CVD) whereas other primary CVD prevention therapies... fail to do so." This evidence represents a paradigm shift in how we understand both menopause management and cardiovascular disease prevention in women.

The cardiovascular benefits of HRT are most pronounced when treatment is initiated early in the menopausal transition, typically within ten years of the final menstrual period or before age sixty. This timing hypothesis suggests that there's a critical window during which HRT can provide maximum cardiovascular protection. When started during this window, HRT has been associated with reduced arterial stiffness, improved endothelial function, favourable changes in lipid profiles, and decreased progression of atherosclerosis.

Research has consistently demonstrated that women who begin HRT during this optimal window experience significant reductions in coronary artery disease, heart attacks, and cardiovascular mortality. The mechanisms behind these benefits are multifaceted. Oestrogen therapy helps maintain the flexibility and responsiveness of blood vessel walls, prevents the oxidation of LDL cholesterol (the "bad" cholesterol that contributes to plaque formation), and supports healthy blood pressure regulation. Additionally, HRT can help prevent the metabolic changes that increase cardiovascular risk, including the redistribution of body fat to the abdominal area and the development of insulin resistance.

It's important to note that the type and route of HRT administration can influence cardiovascular outcomes. Transdermal oestrogen (delivered via patches or gels) may offer advantages over oral preparations for women with certain risk factors, as it bypasses first-pass metabolism through the liver and has less impact on clotting factors and inflammatory markers. At Bodyline Clinic, our specialist menopause practitioners carefully consider each woman's individual cardiovascular risk profile when developing personalised HRT treatment plans.

Understanding HRT: More Than Just Symptom Relief

HRT is a treatment used to replace the hormones that have depleted over the course of perimenopause and menopause in women. This therapy treatment comes in the form of gels, creams, pills, and patches and can be made bespoke for each individual patient's needs based on blood analysis. HRT can replace oestrogen and progesterone, the main female reproductive hormones created in the ovaries, as well as dehydroepiandrosterone (DHEA) which aids in the production of oestrogen and progesterone. HRT can also include testosterone.

The sophistication of modern HRT prescribing has evolved considerably from the one-size-fits-all approaches of the past. Today's hormone replacement therapy protocols recognise that every woman's hormonal needs are unique, influenced by factors including her age, the timing of menopause (natural or surgical), her symptom profile, medical history, and personal preferences. This personalised approach is central to the treatment philosophy at Bodyline Clinic, where comprehensive blood testing and detailed consultations inform individually tailored treatment plans.

Oestrogen replacement forms the cornerstone of HRT for most women, addressing the primary hormonal deficiency of menopause. However, women who have not had a hysterectomy also require progesterone (or a synthetic progestogen) to protect the uterine lining from the proliferative effects of oestrogen alone. The choice between different types of progesterone—including body-identical micronised progesterone versus synthetic progestogens—can impact both symptom relief and cardiovascular risk profiles, making expert prescribing essential.

Testosterone supplementation, whilst less commonly discussed, can be an important component of comprehensive HRT for many women. Testosterone levels naturally decline with age and drop further after menopause, contributing to reduced energy, diminished libido, decreased muscle mass, and impaired cognitive function. For working women, these symptoms can significantly impact professional performance and career satisfaction. Appropriately dosed testosterone therapy can help restore energy levels, improve concentration, support bone and muscle health, and enhance overall wellbeing.

The delivery method of HRT also matters significantly. Transdermal preparations (patches, gels, and creams) offer several advantages, particularly for cardiovascular health. They provide steady hormone levels throughout the day, avoid the peaks and troughs associated with some oral preparations, and bypass the liver's first-pass metabolism, which can be beneficial for women with certain risk factors. Bodyline's bespoke hormone replacement therapy approach considers all these factors when determining the optimal treatment regimen for each patient.

The Mechanism: How HRT Protects Your Heart

The reason HRT is proven to support heart health and reduce risk of heart disease is because oestrogen keeps the arteries opened and relaxed, preventing cholesterol from building up and potentially clogging. When oestrogen is no longer created naturally, fat is more likely to block arteries to the heart and brain, which can lead to cardiovascular disease. This explanation, whilst accurate, only scratches the surface of oestrogen's complex cardiovascular effects.

Oestrogen's cardiovascular benefits operate through multiple interconnected mechanisms. At the cellular level, oestrogen receptors are present throughout the cardiovascular system, including in the heart muscle itself, the lining of blood vessels (endothelium), and smooth muscle cells within arterial walls. When oestrogen binds to these receptors, it triggers a cascade of beneficial effects. The endothelium produces more nitric oxide, a molecule that causes blood vessels to dilate and improves blood flow. This vasodilatory effect helps maintain healthy blood pressure and ensures adequate oxygen delivery to tissues throughout the body.

Beyond its effects on blood vessels, oestrogen influences lipid metabolism in ways that protect against atherosclerosis. It tends to increase HDL cholesterol (the "good" cholesterol that helps remove excess cholesterol from arteries) whilst decreasing LDL cholesterol and total cholesterol levels. Oestrogen also affects how cholesterol particles are processed, favouring larger, less atherogenic LDL particles over the small, dense particles that more readily penetrate arterial walls and contribute to plaque formation.

The hormone also exerts anti-inflammatory effects that are relevant to cardiovascular health. Chronic inflammation plays a central role in the development and progression of atherosclerosis, and oestrogen helps modulate inflammatory processes, reducing levels of pro-inflammatory markers such as C-reactive protein. Additionally, oestrogen influences glucose metabolism and insulin sensitivity, helping to prevent the metabolic dysfunction that increases cardiovascular risk. For working women managing the demands of professional life, these metabolic benefits can translate to better energy levels, improved mental clarity, and enhanced physical stamina.

Addressing Multiple Risk Factors Simultaneously

Additionally, HRT can help with the symptoms of menopause that also contribute to a woman's rising risk of cardiovascular disease. These include increased visceral fat in the abdomen, difficulties with sleeping, and cholesterol levels. Research shows that menopausal HRT has been calculated to substantially lower the economic burden from menopausal symptoms and chronic diseases. Targeting the root cause of cardiovascular disease risk in women after the menopause could be the best solution to improving risk of strokes and heart attacks in working women.

The relationship between menopausal symptoms and cardiovascular risk is bidirectional and complex. Sleep disruption, one of the most common and distressing menopausal symptoms, doesn't just affect daytime functioning—it also has profound cardiovascular implications. Poor sleep quality and insufficient sleep duration are associated with hypertension, increased inflammation, impaired glucose metabolism, and elevated cardiovascular disease risk. Night sweats and hot flushes can fragment sleep architecture, preventing women from achieving the deep, restorative sleep stages necessary for cardiovascular health and metabolic regulation.

By effectively managing vasomotor symptoms like hot flushes and night sweats, HRT can significantly improve sleep quality. This improvement has cascading benefits: better sleep supports healthy blood pressure regulation, improves insulin sensitivity, reduces stress hormone levels, and enhances cognitive function. For working women, these improvements translate directly to better job performance, enhanced decision-making capabilities, and increased resilience in managing workplace challenges.

The impact of HRT on body composition represents another crucial cardiovascular benefit. The menopausal transition is characterised by a shift in fat distribution, with increased accumulation of visceral adipose tissue around internal organs, particularly in the abdominal cavity. This visceral fat is metabolically active, secreting inflammatory cytokines and hormones that promote insulin resistance, dyslipidaemia, and hypertension. HRT helps prevent or slow this unfavourable change in body composition, helping women maintain a healthier fat distribution pattern that's associated with lower cardiovascular risk.

The psychological benefits of HRT also contribute indirectly to cardiovascular health. Anxiety and depression, which affect a substantial proportion of menopausal women, are themselves independent risk factors for cardiovascular disease. The mechanisms linking mental health and heart health include effects on the autonomic nervous system, inflammatory processes, health behaviours, and adherence to medical recommendations. By alleviating mood symptoms, improving sleep, and enhancing overall quality of life, HRT can help break the cycle linking psychological distress and cardiovascular risk.

Reducing Workplace Stress and Its Cardiovascular Impact

Moreover, HRT can remove the stress, both physically and mentally, for working women going through the menopause. By reducing symptom severity, working women can continue to focus on their careers rather than the stigma and issues that the menopause has historically caused in work environments. This stress can of course also be contributing to increased risk of heart problems, as the British Heart Foundation sees a link between stress and unhealthy coping habits.

Chronic workplace stress is a well-established cardiovascular risk factor, operating through both direct physiological pathways and indirect behavioural mechanisms. When women struggle with unmanaged menopausal symptoms at work, the stress response is activated repeatedly throughout the day. This chronic activation leads to sustained elevation of stress hormones like cortisol and adrenaline, which over time can contribute to hypertension, increased heart rate variability, endothelial dysfunction, and promotion of atherosclerosis.

The cognitive symptoms of menopause—including difficulty concentrating, memory lapses, and reduced mental clarity—can be particularly stressful for women in demanding professional roles. When a previously high-performing executive or manager suddenly struggles to recall information in meetings, loses track of conversations, or finds it difficult to multitask as effectively as before, the psychological impact can be devastating. The fear of appearing incompetent, concerns about job security, and the effort required to compensate for cognitive changes create a constant state of stress that takes a toll on both mental and cardiovascular health.

Effective HRT can alleviate these cognitive symptoms, restoring confidence and professional capability. Women often report that once their hormones are optimally balanced, they experience a return of mental sharpness, improved memory, and enhanced ability to manage complex tasks. This cognitive restoration not only improves work performance but also reduces the stress associated with struggling to maintain professional standards whilst battling menopausal symptoms. The confidence that comes with feeling mentally sharp and physically capable translates to better stress management and, consequently, better cardiovascular health.

Furthermore, when menopausal symptoms are well-managed, women are less likely to resort to unhealthy coping mechanisms. Unmanaged symptoms can lead to increased consumption of caffeine (to combat fatigue), alcohol (to manage stress or aid sleep), and comfort foods high in sugar and fat (to cope with mood changes). These coping strategies, whilst understandable, contribute to cardiovascular risk. By addressing symptoms at their hormonal root, HRT can help women maintain healthier lifestyle habits that support both immediate wellbeing and long-term cardiovascular health.

The Business Case for Corporate Menopause Support

We offer corporate solutions for menopausal employees, with the aim of improving their life quality, retaining hundreds of thousands of women within the UK workforce, and boosting the health and happiness of working menopausal women across the country. The business case for supporting menopausal employees extends far beyond corporate social responsibility—it represents a strategic investment in organisational performance, talent retention, and workforce sustainability.

"Healthier employees mean happier employees. There's less absenteeism, improved productivity and lowered health care premium costs." This observation from Jim Link of the Society for Human Resource Management encapsulates the fundamental business logic behind workplace health initiatives. When applied specifically to menopause support, the return on investment can be particularly compelling given the seniority and experience level of the affected demographic.

Consider the financial implications of losing experienced female leaders and professionals to early retirement or career changes precipitated by unmanaged menopausal symptoms. The replacement costs alone—including recruitment fees, onboarding expenses, and the productivity loss during the learning curve—can easily exceed 150% of an employee's annual salary for senior positions. Beyond these direct costs, organisations lose the institutional knowledge, client relationships, mentorship capabilities, and cultural influence these women provide. The cumulative effect on organisational performance can be substantial, particularly in sectors where women represent a significant proportion of senior leadership.

Absenteeism related to menopausal symptoms represents another significant cost. When women take sick leave due to severe hot flushes, debilitating fatigue, or mental health challenges related to menopause, the immediate impact on team productivity is obvious. However, the less visible phenomenon of presenteeism—being physically present at work but functioning at reduced capacity—may actually represent a greater productivity drain. Women struggling with concentration difficulties, fatigue, or anxiety may be at their desks but operating at perhaps 60-70% of their normal capability, and this reduced effectiveness can persist for months or even years without appropriate treatment.

Healthcare costs associated with cardiovascular disease and other chronic conditions linked to menopause represent another area where preventative investment can yield substantial returns. Cardiovascular events are expensive, both in terms of immediate medical costs and ongoing management of chronic conditions. By supporting access to HRT and other evidence-based menopause treatments, employers can potentially reduce the incidence of cardiovascular disease in their female workforce, leading to lower health insurance premiums and reduced healthcare utilisation over time.

Creating a Supportive Workplace Culture

With all this in mind, we pose a question to all business owners and their HR teams: what is stopping you from prioritising the health and wellbeing of your menopausal employees? The barriers to implementing comprehensive menopause support are often more perceived than real, and organisations that overcome these barriers position themselves as employers of choice for experienced female talent.

By targeting the root cause of absenteeism, economic costs of early retirement, and a loss of talent and knowledge, corporate HRT solutions can help businesses realise the organisational benefits of supported, healthy, and happy staff. The implementation of menopause support programmes sends a powerful message to the entire workforce: that the organisation values its employees throughout all life stages and is committed to supporting their health and wellbeing in practical, meaningful ways.

We work with companies and in collaboration with partners in the menopause industry to deliver corporate gold standard menopause treatments. When companies invest in their menopausal workforce, they directly remove negative stigmatisation, allow for openness and conversation, and ensure their female staff members feel valued and appreciated at all ages. This cultural shift has benefits that extend beyond the directly affected employees. Younger women in the organisation see that their future career progression won't be derailed by menopause. Male colleagues develop greater understanding and empathy. The entire organisational culture becomes more inclusive, supportive, and psychologically safe.

The ripple effects of menopause-friendly policies can enhance employer brand and talent attraction. In competitive labour markets, organisations known for supporting employees through all life stages have a distinct advantage in recruiting and retaining top talent. Women in their thirties and forties, anticipating their own menopausal transition, increasingly consider menopause support when evaluating potential employers. Similarly, male employees with partners going through menopause value employers who understand and accommodate this life stage.

Beyond Insurance: HRT as Heart Protection

If companies can offer health insurance, dental insurance, and gym memberships for the health of their employees, why can't they offer a heart insurance for their menopausal employees at a higher risk of cardiovascular disease by giving them access to HRT? This question cuts to the heart of how we conceptualise employee benefits and preventative health investment in the modern workplace.

Traditional employee benefits often focus on acute health needs or general wellness initiatives whilst overlooking specific, high-impact interventions for particular demographic groups. Yet the evidence for HRT as a cardiovascular protective intervention for menopausal women is stronger than the evidence supporting many routinely offered wellness benefits. A gym membership provides value only if employees use it regularly; HRT, when appropriately prescribed and monitored, delivers measurable cardiovascular and metabolic benefits regardless of whether the employee also exercises regularly (though combining both is optimal).

The concept of HRT as "heart insurance" is particularly apt given the timing-dependent nature of its cardiovascular benefits. Just as traditional insurance is most valuable when obtained before a problem occurs, HRT provides maximum cardiovascular protection when initiated early in the menopausal transition. Waiting until cardiovascular disease has already developed means missing the critical window for prevention. Forward-thinking employers who facilitate early access to menopause assessment and treatment are essentially providing preventative cardiovascular care to a high-risk demographic within their workforce.

From a health economics perspective, the cost of providing access to HRT is modest compared to the potential costs of cardiovascular disease. A year's supply of HRT, including consultations and monitoring, costs a fraction of what a single cardiovascular event costs in terms of immediate medical care, rehabilitation, lost productivity, and ongoing disease management. When viewed through this lens, corporate menopause support programmes represent not an expense but an investment with potentially significant returns in terms of reduced healthcare costs and maintained workforce productivity.

Building Fairness and Equity in the Workplace

Let's contribute to a fair, beneficial, and caring work environment in the UK by prioritising the health and retention of employees who are first and foremost talented and experienced as well as menopausal. The principle of workplace equity requires that we recognise and accommodate the different health needs that arise at different life stages. Just as organisations make accommodations for pregnancy and parenting, menopause deserves similar recognition and support.

The intersection of menopause and workplace equity is particularly relevant given the gender pay gap and the underrepresentation of women in senior leadership. Women reaching their peak earning and leadership potential often face menopause at precisely the moment when they should be capitalising on decades of experience and expertise. When menopausal symptoms or health concerns force women to reduce hours, decline promotions, or exit the workforce entirely, it perpetuates gender inequity at the highest organisational levels. Supporting women through menopause is therefore not just a health issue but a diversity, equity, and inclusion imperative.

Creating a fair workplace for menopausal women requires multiple, complementary approaches. Access to high-quality medical care, including HRT when appropriate, forms one crucial pillar. However, comprehensive support also includes workplace adjustments (such as temperature control, flexible working arrangements, and private spaces for managing symptoms), education and awareness programmes for all staff, training for line managers on supporting menopausal employees, and clear policies that normalise menopause as a workplace health issue rather than a taboo topic.

Bodyline's Corporate M Plan: Comprehensive Menopause Support

We offer a complete bespoke clinically supported menopause treatment plan – the M Plan. The M Plan offers an end-to-end solution for individuals and corporates. Bodyline has a consultative approach to ensure that the M Plan delivers positive outcomes for the patient as well as the organisation. The Bodyline way is proven to optimise menopausal women's health and wellbeing and in turn has positive benefits to business performance.

The M Plan represents a comprehensive approach to menopause care that goes beyond simple HRT prescribing. It begins with thorough assessment, including detailed symptom evaluation, medical history review, and comprehensive blood testing to establish baseline hormone levels and identify any contraindications to HRT. This diagnostic phase ensures that treatment recommendations are based on objective data rather than assumptions, allowing for truly personalised care.

Following assessment, women receive individualised treatment plans that may include bespoke hormone replacement therapy tailored to their specific hormonal deficiencies, symptom profile, and cardiovascular risk factors. The M Plan recognises that optimal menopause management often requires more than HRT alone. Nutritional guidance, lifestyle recommendations, stress management strategies, and advice on exercise and sleep optimisation complement hormonal treatment to address menopause holistically.

Ongoing monitoring and support form a critical component of the M Plan. Hormone levels and symptoms are reassessed regularly, allowing for treatment adjustments to ensure optimal outcomes. This responsive approach recognises that women's needs change over time and that the initial treatment protocol may require refinement. Access to specialist menopause nurses and clinicians ensures that women can discuss concerns, report side effects, and receive guidance whenever needed, providing reassurance and continuity of care.

For corporate clients, Bodyline provides additional support including educational sessions for employees and managers, consultation on workplace policy development, and aggregated (anonymised) data on programme utilisation and outcomes to demonstrate return on investment. This partnership approach ensures that menopause support is integrated into the broader organisational culture and health strategy rather than existing as an isolated benefit.

The convenience and accessibility of Bodyline's service model is designed with working women in mind. With clinics located throughout the Northwest of England including locations in Birkenhead, Liverpool, Manchester, St Helens, Stockport, Stoke-on-Trent, and Warrington, as well as online consultation options available UK-wide, women can access care in a way that fits their schedule and preferences. This flexibility is crucial for busy professionals who may struggle to attend appointments during traditional working hours.

Taking Action: Next Steps for Organisations and Individuals

If you are interested in making use of Bodyline's Corporate M Plan, get in touch today by calling 0800 995 6036 or via our website. Taking the first step towards comprehensive menopause support demonstrates organisational commitment to employee wellbeing and positions your company as a progressive, caring employer that recognises the value of its experienced female workforce.

For individual women experiencing menopausal symptoms or concerned about their cardiovascular health during the menopausal transition, waiting for your employer to implement a corporate programme isn't necessary. Bodyline's menopause services are available to all women, whether accessing care privately or through corporate arrangements. Early intervention is key to maximising both symptom relief and cardiovascular protection, so seeking assessment sooner rather than later is advisable.

Book a consultation at Bodyline Clinic to discuss how hormone replacement therapy could support your cardiovascular health and help you manage menopausal symptoms whilst maintaining your professional performance. Our specialist menopause practitioners will conduct a thorough assessment, explain your treatment options, and develop a personalised plan that addresses your specific needs and health goals. With nearly two decades of experience supporting women through menopause and a commitment to evidence-based, individualised care, Bodyline is uniquely positioned to help you navigate this life stage with confidence and optimal health.

The convergence of menopause support and cardiovascular disease prevention represents an opportunity to transform both women's health outcomes and workplace culture. By recognising menopause as a significant health transition requiring appropriate medical support—including HRT when suitable—we can help women maintain their cardiovascular health, continue thriving in their careers, and contribute their expertise and leadership throughout their working lives. The evidence is clear, the solutions are available, and the time for action is now. Whether you're an employer seeking to support your workforce or a woman navigating menopause yourself, Bodyline's comprehensive, clinically excellent approach to menopause care offers the support and expertise you need to protect your heart health and optimise your wellbeing during this important life transition.